These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3881947

  • 1. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ, Vari AJ, Winslade NE, Swanson DJ, Smith IL, Simons GW, Vigano A.
    Am J Med; 1985 Feb 08; 78(2A):34-41. PubMed ID: 3881947
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
    Nolen TM, Phillips HL, Hall HJ.
    Rev Infect Dis; 1985 Feb 08; 7 Suppl 4():S666-8. PubMed ID: 3909321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL.
    Am J Med; 1990 Mar 23; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE, Neu HC.
    Am J Med; 1985 Feb 23; 78(2):251-61. PubMed ID: 4038574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS, Ramirez-Ronda C, Saavedra S, Rivera-Vázquez CR, Liu C, Hinthorn DR.
    Clin Ther; 1993 Feb 23; 15(1):65-78. PubMed ID: 8458056
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group.
    Brown RB, Kruse JA, Counts GW, Russell JA, Christou NV, Sands ML.
    Antimicrob Agents Chemother; 1990 Feb 23; 34(2):269-72. PubMed ID: 2183716
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V, Gobernado M, Santos M, Rabinad E.
    Chemotherapy; 1989 Feb 23; 35 Suppl 1():81-8. PubMed ID: 2659295
    [Abstract] [Full Text] [Related]

  • 17. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA.
    Rev Infect Dis; 1985 Feb 23; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.